Creative Planning boosted its holdings in shares of TPG Inc. (NASDAQ:TPG – Free Report) by 55.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,784 shares of the company’s stock after buying an additional 3,851 shares during the quarter. Creative Planning’s holdings in TPG were worth $621,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. International Assets Investment Management LLC acquired a new stake in TPG during the 2nd quarter worth approximately $25,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of TPG in the first quarter valued at about $112,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of TPG in the first quarter valued at about $151,000. MQS Management LLC acquired a new position in shares of TPG in the first quarter valued at about $201,000. Finally, Jaffetilchin Investment Partners LLC bought a new position in TPG during the first quarter worth about $209,000. Institutional investors own 86.79% of the company’s stock.
Wall Street Analyst Weigh In
TPG has been the topic of a number of analyst reports. TD Cowen decreased their target price on shares of TPG from $44.00 to $42.00 and set a “hold” rating on the stock in a research report on Monday, July 8th. Wells Fargo & Company increased their price target on TPG from $60.00 to $67.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 9th. Evercore ISI lifted their price objective on TPG from $46.00 to $60.00 and gave the company an “in-line” rating in a report on Monday, October 14th. JPMorgan Chase & Co. increased their target price on TPG from $44.00 to $49.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Finally, The Goldman Sachs Group raised their price target on TPG from $60.00 to $63.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $52.25.
TPG Trading Down 6.3 %
Shares of TPG stock opened at $61.79 on Tuesday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.37. The firm has a market cap of $22.54 billion, a P/E ratio of -174.17, a price-to-earnings-growth ratio of 1.07 and a beta of 1.49. The business has a 50-day moving average price of $58.52 and a two-hundred day moving average price of $49.13. TPG Inc. has a 12-month low of $28.93 and a 12-month high of $69.86.
TPG (NASDAQ:TPG – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.06. The business had revenue of $744.19 million for the quarter, compared to analyst estimates of $449.34 million. TPG had a return on equity of 24.27% and a net margin of 1.08%. During the same period last year, the company earned $0.26 EPS. Equities analysts anticipate that TPG Inc. will post 1.96 EPS for the current fiscal year.
TPG Profile
TPG Inc operates as an alternative asset manager in the United States and internationally. The company offers investment management services to TPG Funds, limited partners, and other vehicles. It also offers monitoring services to portfolio companies; advisory, debt and equity arrangement, and underwriting and placement services; and capital structuring and other advisory services to portfolio companies.
Recommended Stories
- Five stocks we like better than TPG
- The Basics of Support and Resistance
- Intel: Is Now the Time to Be Brave?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 5 Top Rated Dividend Stocks to Consider
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Want to see what other hedge funds are holding TPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TPG Inc. (NASDAQ:TPG – Free Report).
Receive News & Ratings for TPG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TPG and related companies with MarketBeat.com's FREE daily email newsletter.